Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-025-03366-1, but it redirected us to https://cardiothoracicsurgery.biomedcentral.com/articles/10.1186/s13019-025-03366-1. The analysis below is for the second page.

Title[redir]:
Inhibition of mir-155-5p alleviates cardiomyocyte pyroptosis induced by hypoxia/reoxygenation via targeting SIRT1-mediated activation of the NLRP3 inflammasome | Journal of Cardiothoracic Surgery | Full Text
Description:
Objective The hypoxia/reoxygenation (H/R)-induced pyroptosis of cardiomyocytes plays a crucial role in the pathogenesis of myocardial infarction (MI). miR-155-5p represents a promising target for MI therapy. However, its involvement in H/R-induced pyroptosis remains unclear. Methods The H/R exposed rat cardiomyocyte H9c2 was utilized as in vitro model, and the expression levels of miR-155-5p and SIRT1 in cells were modulated through cell transfection experiments. Cell proliferative activity was assessed using the Cell counting kit-8 assay. Supernatant lactate dehydrogenase (LDH) activity was determined through colorimetry. The levels of living and dead cell were observed via Calcin-AM/PI staining. Levels of supernatant interleukin (IL)-1β and IL-18 were measured using ELISA assay. The expression levels of miR-155-5p and silent information regulator 1 (SIRT1) mRNA were detected by qRT-PCR. The protein expression levels of SIRT1, NLRP3, N-terminal gasdermin D (GSDMD-N), and Cleaved caspase-1 were evaluated using Western blot analysis. The targeted regulatory relationship between miR-155-5p and SIRT1 was verified using dual luciferase reporter gene assay. Results The proliferation activity of H9c2 cells induced by H/R was attenuated, accompanied by severe injury, increased cell death, and the release of a substantial amount of pro-inflammatory cytokines IL-1β and IL-18. In addition, H/R stimulation resulted in the upregulation of miR-155-5p expression and downregulation of SIRT1 expression in H9c2 cells. Suppression of miR-155-5p or overexpression of SIRT1 exhibited ameliorative effects on H/R-induced cellular injury in H9c2 cells and inhibited NLRP3 inflammasome-mediated pyroptosis. The dual-luciferase assay confirmed the direct targeting of SIRT1 by miR-155-5p in H9c2 cells. Furthermore, partial reversal of the inhibitory effect of miR-155-5p inhibitor on H/R-induced NLRP3 inflammasome-mediated pyroptosis in H9c2 cells was observed upon interference with SIRT1 expression. Conclusion Inhibition of miR-155-5p alleviates cardiomyocyte pyroptosis induced by H/R via targeting SIRT1-mediated activation of the NLRP3 inflammasome.

Matching Content Categories {šŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {šŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of doi.org audience?

šŸš„ Respectable Traffic: 10k - 20k visitors per month


Based on our best estimate, this website will receive around 10,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {šŸ’ø}

We can't see how the site brings in money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {šŸ”}

cells, mirp, sirt, pyroptosis, pubmed, myocardial, nlrp, cell, article, expression, google, scholar, injury, levels, inflammasome, cas, fig, inhibition, protein, death, cardiomyocyte, central, activity, assay, activation, cardiomyocytes, inhibitor, hrinduced, level, induced, targeting, supernatant, analysis, infarction, wang, ldh, ilβ, western, blot, cardiac, inflammatory, demonstrated, china, overexpression, study, exposure, observed, gsdmdn, significant, data,

Topics {āœ’ļø}

tlr4/nf-κb p65 pathway springer nature p53/mir-155-5p/sirt1 loop additional information publisher induced nlrp3-mediated pyroptosis post-myocardial infarction remodelling nlrp3 inflammasome-mediated pyroptosis pro-inflammatory cytokines il-1β sirt1/nf-κb pathway hypoxic-ischemic brain damage visualized figures mir-665/mef2d/nrf2 axis myocardial ischemia-reperfusion injury myocardial ischemia/reperfusion injury mir-155-5p promotes pyroptosis /r-induced cellular injury references peng post-myocardial infarction patients post-resuscitation cardiac dysfunction hypoxic-ischemic brain injury dual-lucy assay kit pyroptosis-inducing cancer drugs author information authors release pro-inflammatory cytokines /r-induced h9c2 cells si-sirt1 effectively counteracted downregulated mir-155-5p expression mir-155-5p effectively attenuated mir-155-5p/sirt1 axis materials independent sample t-test sharing /r-exposed h9c2 cells c-terminal domain connected /r-induced damage cardiomyocyte pyroptosis induced mir-155-5p regulates pyroptosis methods cell culture privacy choices/manage cookies dual-luciferase assay confirmed targeting sirt1-mediated activation acute myocardial infarction authors scientific editing results pyroptosis mediated /r-induced pyroptosis data availability state privacy rights mir-155-5p inhibitor resulted bmc induced cardiomyocyte apoptosis

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Inhibition of mir-155-5p alleviates cardiomyocyte pyroptosis induced by hypoxia/reoxygenation via targeting SIRT1-mediated activation of the NLRP3 inflammasome
         description:The hypoxia/reoxygenation (H/R)-induced pyroptosis of cardiomyocytes plays a crucial role in the pathogenesis of myocardial infarction (MI). miR-155-5p represents a promising target for MI therapy. However, its involvement in H/R-induced pyroptosis remains unclear. The H/R exposed rat cardiomyocyte H9c2 was utilized as in vitro model, and the expression levels of miR-155-5p and SIRT1 in cells were modulated through cell transfection experiments. Cell proliferative activity was assessed using the Cell counting kit-8 assay. Supernatant lactate dehydrogenase (LDH) activity was determined through colorimetry. The levels of living and dead cell were observed via Calcin-AM/PI staining. Levels of supernatant interleukin (IL)-1β and IL-18 were measured using ELISA assay. The expression levels of miR-155-5p and silent information regulator 1 (SIRT1) mRNA were detected by qRT-PCR. The protein expression levels of SIRT1, NLRP3, N-terminal gasdermin D (GSDMD-N), and Cleaved caspase-1 were evaluated using Western blot analysis. The targeted regulatory relationship between miR-155-5p and SIRT1 was verified using dual luciferase reporter gene assay. The proliferation activity of H9c2 cells induced by H/R was attenuated, accompanied by severe injury, increased cell death, and the release of a substantial amount of pro-inflammatory cytokines IL-1β and IL-18. In addition, H/R stimulation resulted in the upregulation of miR-155-5p expression and downregulation of SIRT1 expression in H9c2 cells. Suppression of miR-155-5p or overexpression of SIRT1 exhibited ameliorative effects on H/R-induced cellular injury in H9c2 cells and inhibited NLRP3 inflammasome-mediated pyroptosis. The dual-luciferase assay confirmed the direct targeting of SIRT1 by miR-155-5p in H9c2 cells. Furthermore, partial reversal of the inhibitory effect of miR-155-5p inhibitor on H/R-induced NLRP3 inflammasome-mediated pyroptosis in H9c2 cells was observed upon interference with SIRT1 expression. Inhibition of miR-155-5p alleviates cardiomyocyte pyroptosis induced by H/R via targeting SIRT1-mediated activation of the NLRP3 inflammasome.
         datePublished:2025-02-19T00:00:00Z
         dateModified:2025-02-19T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1186/s13019-025-03366-1
         keywords:
            Myocardial infarction
            Hypoxia/reoxygenation
            Cardiomyocyte
            Pyroptosis
            NLRP3 inflammasome
            Cardiac Surgery
            Thoracic Surgery
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig5_HTML.png
         isPartOf:
            name:Journal of Cardiothoracic Surgery
            issn:
               1749-8090
            volumeNumber:20
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Qiuyu Lu
               affiliation:
                     name:People’s Hospital of Guangxi Zhuang Autonomous Region
                     address:
                        name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qingrong Shen
               affiliation:
                     name:People’s Hospital of Guangxi Zhuang Autonomous Region
                     address:
                        name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jinmei Su
               affiliation:
                     name:Mingxiu Branch of Guangxi International Zhuang Medicine Hospital
                     address:
                        name:Department of Pharmacy, Mingxiu Branch of Guangxi International Zhuang Medicine Hospital, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin Li
               affiliation:
                     name:Guangxi University of Chinese Medicine
                     address:
                        name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bingyu Xia
               affiliation:
                     name:Guangxi University of Chinese Medicine
                     address:
                        name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aicun Tang
               affiliation:
                     name:Guangxi University of Chinese Medicine
                     address:
                        name:Guangxi University of Chinese Medicine, Nanning, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Inhibition of mir-155-5p alleviates cardiomyocyte pyroptosis induced by hypoxia/reoxygenation via targeting SIRT1-mediated activation of the NLRP3 inflammasome
      description:The hypoxia/reoxygenation (H/R)-induced pyroptosis of cardiomyocytes plays a crucial role in the pathogenesis of myocardial infarction (MI). miR-155-5p represents a promising target for MI therapy. However, its involvement in H/R-induced pyroptosis remains unclear. The H/R exposed rat cardiomyocyte H9c2 was utilized as in vitro model, and the expression levels of miR-155-5p and SIRT1 in cells were modulated through cell transfection experiments. Cell proliferative activity was assessed using the Cell counting kit-8 assay. Supernatant lactate dehydrogenase (LDH) activity was determined through colorimetry. The levels of living and dead cell were observed via Calcin-AM/PI staining. Levels of supernatant interleukin (IL)-1β and IL-18 were measured using ELISA assay. The expression levels of miR-155-5p and silent information regulator 1 (SIRT1) mRNA were detected by qRT-PCR. The protein expression levels of SIRT1, NLRP3, N-terminal gasdermin D (GSDMD-N), and Cleaved caspase-1 were evaluated using Western blot analysis. The targeted regulatory relationship between miR-155-5p and SIRT1 was verified using dual luciferase reporter gene assay. The proliferation activity of H9c2 cells induced by H/R was attenuated, accompanied by severe injury, increased cell death, and the release of a substantial amount of pro-inflammatory cytokines IL-1β and IL-18. In addition, H/R stimulation resulted in the upregulation of miR-155-5p expression and downregulation of SIRT1 expression in H9c2 cells. Suppression of miR-155-5p or overexpression of SIRT1 exhibited ameliorative effects on H/R-induced cellular injury in H9c2 cells and inhibited NLRP3 inflammasome-mediated pyroptosis. The dual-luciferase assay confirmed the direct targeting of SIRT1 by miR-155-5p in H9c2 cells. Furthermore, partial reversal of the inhibitory effect of miR-155-5p inhibitor on H/R-induced NLRP3 inflammasome-mediated pyroptosis in H9c2 cells was observed upon interference with SIRT1 expression. Inhibition of miR-155-5p alleviates cardiomyocyte pyroptosis induced by H/R via targeting SIRT1-mediated activation of the NLRP3 inflammasome.
      datePublished:2025-02-19T00:00:00Z
      dateModified:2025-02-19T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1186/s13019-025-03366-1
      keywords:
         Myocardial infarction
         Hypoxia/reoxygenation
         Cardiomyocyte
         Pyroptosis
         NLRP3 inflammasome
         Cardiac Surgery
         Thoracic Surgery
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13019-025-03366-1/MediaObjects/13019_2025_3366_Fig5_HTML.png
      isPartOf:
         name:Journal of Cardiothoracic Surgery
         issn:
            1749-8090
         volumeNumber:20
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Qiuyu Lu
            affiliation:
                  name:People’s Hospital of Guangxi Zhuang Autonomous Region
                  address:
                     name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qingrong Shen
            affiliation:
                  name:People’s Hospital of Guangxi Zhuang Autonomous Region
                  address:
                     name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jinmei Su
            affiliation:
                  name:Mingxiu Branch of Guangxi International Zhuang Medicine Hospital
                  address:
                     name:Department of Pharmacy, Mingxiu Branch of Guangxi International Zhuang Medicine Hospital, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin Li
            affiliation:
                  name:Guangxi University of Chinese Medicine
                  address:
                     name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bingyu Xia
            affiliation:
                  name:Guangxi University of Chinese Medicine
                  address:
                     name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aicun Tang
            affiliation:
                  name:Guangxi University of Chinese Medicine
                  address:
                     name:Guangxi University of Chinese Medicine, Nanning, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Cardiothoracic Surgery
      issn:
         1749-8090
      volumeNumber:20
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:People’s Hospital of Guangxi Zhuang Autonomous Region
      address:
         name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
         type:PostalAddress
      name:People’s Hospital of Guangxi Zhuang Autonomous Region
      address:
         name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
         type:PostalAddress
      name:Mingxiu Branch of Guangxi International Zhuang Medicine Hospital
      address:
         name:Department of Pharmacy, Mingxiu Branch of Guangxi International Zhuang Medicine Hospital, Nanning, China
         type:PostalAddress
      name:Guangxi University of Chinese Medicine
      address:
         name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
         type:PostalAddress
      name:Guangxi University of Chinese Medicine
      address:
         name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
         type:PostalAddress
      name:Guangxi University of Chinese Medicine
      address:
         name:Guangxi University of Chinese Medicine, Nanning, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Qiuyu Lu
      affiliation:
            name:People’s Hospital of Guangxi Zhuang Autonomous Region
            address:
               name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
               type:PostalAddress
            type:Organization
      name:Qingrong Shen
      affiliation:
            name:People’s Hospital of Guangxi Zhuang Autonomous Region
            address:
               name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
               type:PostalAddress
            type:Organization
      name:Jinmei Su
      affiliation:
            name:Mingxiu Branch of Guangxi International Zhuang Medicine Hospital
            address:
               name:Department of Pharmacy, Mingxiu Branch of Guangxi International Zhuang Medicine Hospital, Nanning, China
               type:PostalAddress
            type:Organization
      name:Xin Li
      affiliation:
            name:Guangxi University of Chinese Medicine
            address:
               name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
               type:PostalAddress
            type:Organization
      name:Bingyu Xia
      affiliation:
            name:Guangxi University of Chinese Medicine
            address:
               name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
               type:PostalAddress
            type:Organization
      name:Aicun Tang
      affiliation:
            name:Guangxi University of Chinese Medicine
            address:
               name:Guangxi University of Chinese Medicine, Nanning, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
      name:Department of Pharmacy, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
      name:Department of Pharmacy, Mingxiu Branch of Guangxi International Zhuang Medicine Hospital, Nanning, China
      name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
      name:Graduate School, Guangxi University of Chinese Medicine, Nanning, China
      name:Guangxi University of Chinese Medicine, Nanning, China

External Links {šŸ”—}(304)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Prism.js

Emails and Hosting {āœ‰ļø}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {šŸ“¦}

  • Crossref

4.1s.